Palo Capital’s Omega Protein OME Stock Holding History

Palo Capital’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-21,200	Closed	-$424K	–	221
2016 Q2	$424K	Buy	+21,200	New	+$396K	0.15%	129

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Palo Capital's OME Position: Q3 2016 in Review

Palo Capital sold out of Omega Protein (OME) in Q3 2016, closing a stake of 21,200 shares — an estimated $424K sold.

Palo Capital first reported a position in OME in Q2 2016 and held it in 1 quarter. The position peaked at $424K in Q2 2016. 155 funds tracked by Wall St. Rank hold OME as of Q3 2016.

Palo Capital reported no remaining Omega Protein position as of Q3 2016 after selling out during the quarter.
Palo Capital sold 21,200 Omega Protein shares in Q3 2016, an estimated $424K.
Palo Capital first reported a position in Omega Protein in Q2 2016 and held it in 1 quarter.
Palo Capital's Omega Protein position peaked at $424K in Q2 2016.
155 funds tracked by Wall St. Rank held Omega Protein as of Q3 2016.

Based on Palo Capital's 13F filing for Q3 2016, filed 20 Oct 2016.